Mice with reduced NMDA receptor expression display behaviors related to schizophrenia

被引:835
作者
Mohn, AR
Gainetdinov, RR
Caron, MG
Koller, BH [1 ]
机构
[1] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA
[3] Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Cell Biol & Med, Durham, NC 27710 USA
关键词
D O I
10.1016/S0092-8674(00)81972-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
N-methyl-D-aspartate receptors (NMDARs) represent a subclass of glutamate receptors that play a critical role in neuronal development and physiology. We report here the generation of mice expressing only 5% of normal levels of the essential NMDAR1 (NR1) subunit. Unlike NR1 null mice, these mice survive to adulthood and display behavioral abnormalities, including increased motor activity and stereotypy and deficits in social and sexual interactions. These behavioral alterations are similar to those observed in pharmacologically induced animal models of schizophrenia and can be ameliorated by treatment with haloperidol or clozapine, antipsychotic drugs that antagonize dopaminergic and serotonergic receptors. These findings support a model in which reduced NMDA receptor activity results in schizophrenic-like behavior and reveals how pharmacological manipulation of monoaminergic pathways can affect this phenotype.
引用
收藏
页码:427 / 436
页数:10
相关论文
共 63 条
[1]   The NMDA antagonist model for schizophrenia: Promise and pitfalls [J].
Abi-Saab, WM ;
D'Souza, DC ;
Moghaddam, B ;
Krystal, JH .
PHARMACOPSYCHIATRY, 1998, 31 :104-109
[2]   MPTP LESIONS OF THE NIGROSTRIATAL DOPAMINERGIC PROJECTION DECREASE [H-3] 1-[1-(2-THIENYL)CYCLOHEXYL]-PIPERIDINE BINDING TO PCP SITE-2 - FURTHER EVIDENCE THAT PCP SITE-2 IS ASSOCIATED WITH THE BIOGENIC-AMINE REUPTAKE COMPLEX [J].
AKUNNE, HC ;
JOHANNESSEN, JN ;
DECOSTA, BR ;
RICE, KC ;
ROTHMAN, RB .
NEUROCHEMICAL RESEARCH, 1992, 17 (03) :261-264
[3]   RECEPTOR ACTIVITY AND TURNOVER OF DOPAMINE AND NORADRENALINE AFTER NEUROLEPTICS [J].
ANDEN, NE ;
BUTCHER, SG ;
CORRODI, H ;
FUXE, K ;
UNGERSTEDT, U .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1970, 11 (03) :303-+
[4]   AMPHETAMINE PSYCHOSIS - BEHAVIORAL AND BIOCHEMICAL ASPECTS [J].
ANGRIST, B ;
SATHANANTHAN, G ;
WILK, S ;
GERSHON, S .
JOURNAL OF PSYCHIATRIC RESEARCH, 1974, 11 :13-23
[5]  
BAN TA, 1984, PSYCHIAT DEV, V2, P179
[6]  
*BRANB C GEN BACKG, 1997, NEURON, V20, P755
[7]   Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications [J].
Carlsson, A ;
Hansson, LO ;
Waters, N ;
Carlsson, ML .
LIFE SCIENCES, 1997, 61 (02) :75-94
[8]   INTERACTIONS BETWEEN GLUTAMATERGIC AND MONOAMINERGIC SYSTEMS WITHIN THE BASAL GANGLIA - IMPLICATIONS FOR SCHIZOPHRENIA AND PARKINSONS-DISEASE [J].
CARLSSON, M ;
CARLSSON, A .
TRENDS IN NEUROSCIENCES, 1990, 13 (07) :272-276
[9]   ANTIPSYCHOTIC AGENTS ANTAGONIZE NONCOMPETITIVE N-METHYL-D-ASPARTATE ANTAGONIST-INDUCED BEHAVIORS [J].
CORBETT, R ;
CAMACHO, F ;
WOODS, AT ;
KERMAN, LL ;
FISHKIN, RJ ;
BROOKS, K ;
DUNN, RW .
PSYCHOPHARMACOLOGY, 1995, 120 (01) :67-74
[10]   EFFECTS OF ATYPICAL ANTIPSYCHOTIC AGENTS ON SOCIAL-BEHAVIOR IN RODENTS [J].
CORBETT, R ;
HARTMAN, H ;
KERMAN, LL ;
WOODS, AT ;
STRUPCZEWSKI, JT ;
HELSLEY, GC ;
CONWAY, PC ;
DUNN, RW .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 45 (01) :9-17